Medicare Enrolled

Dr. Ajay Kwatra, MD

Urology Physician · Conroe, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
690 S LOOP 336 W, Conroe, TX 77304
9364411005
In practice since 2006 (19 years)
NPI: 1215024195 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kwatra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kwatra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kwatra

Dr. Ajay Kwatra is an urology physician in Conroe, TX, with 19 years in practice. Based on federal Medicare data, Dr. Kwatra performed 492,972 Medicare services across 11,159 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kwatra received a total of $9,320 from 28 pharmaceutical and/or device companies across 162 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kwatra is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 0% volume in TX$ $9,320 industry payments

Medicare Practice Summary

Medicare Utilization ↗
492,972
Medicare services
Top 0% in TX for urology physician
11,159
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~25,946 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Testosterone injection421,305$0$0
Identification of organisms by genetic analysis, amplified probe technique30,552$34$88
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique7,638$68$175
Infectious disease DNA/RNA test5,097$34$44
Yeast/candida DNA test5,092$34$100
Office visit, established patient (30-39 min)2,827$85$313
Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique2,548$34$88
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique2,548$34$88
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique2,548$34$100
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique2,547$34$88
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique2,547$34$88
Office visit, established patient (20-29 min)1,643$61$213
Bladder ultrasound after voiding1,468$7$55
Drug injection, under skin or into muscle1,370$10$73
Ceftriaxone antibiotic injection824$0$2
Injection, garamycin, gentamicin, up to 80 mg384$2$5
Hospital follow-up visit, moderate complexity381$55$214
Electronic assessment of bladder emptying270$10$90
New patient office visit (45-59 min)217$111$478
Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm177$565$1,992
Urinalysis, manual173$3$11
Leuprolide acetate (for depot suspension), 7.5 mg150$125$663
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle139$24$93
Complicated change of bladder tube81$96$375
Simple bladder irrigation and/or instillation80$41$211
Shock wave crushing of kidney stones67$407$1,700
Diagnostic exam of bladder and urethra using an endoscope61$142$478
Complicated insertion of bladder tube44$106$362
Injection, ketorolac tromethamine, per 15 mg41$0$2
Telephone medical discussion with physician, 5-10 minutes36$28$200
Complete laser vaporization of prostate including control of bleeding using an endoscope24$500$2,068
Destruction and/or removal of large growth of bladder using an endoscope22$266$1,182
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies20$271$983
Insertion of device into abdomen with pressure and urine flow rate study20$139$323
Biopsy of prostate gland16$175$722
Ultrasonic guidance for needle placement15$42$176
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,320
Total received (2018-2024)
Avg $1,331/year across 7 years
Top 21% in TX for urology physician
28
Companies
162
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,222 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$98 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$523
2023
$363
2022
$1,586
2021
$2,309
2020
$842
2019
$2,784
2018
$914

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Coloplast Corp
$3,787
Axonics, Inc.
$2,368
COLOPLAST CORP
$725
Astellas Pharma US Inc
$604
Axonics Modulation Technologies, Inc.
$321
PFIZER INC.
$280
Teleflex LLC
$138
Endo Pharmaceuticals Inc.
$133
FORTE BIO-PHARMA LLC
$125
Abbott Laboratories
$108
Boston Scientific Corporation
$101
McKesson Medical-Surgical, Inc.
$94
Antares Pharma, Inc.
$65
DENTSPLY IH Inc.
$52
PROCEPT BioRobotics Corporation
$50
Merck Sharp & Dohme LLC
$45
KARL STORZ Lithotripsy-America, Inc.
$37
Ferring Pharmaceuticals Inc.
$36
Sumitomo Pharma America, Inc.
$34
AbbVie Inc.
$32
Blue Earth Diagnostics Limited
$30
Myriad Genetic Laboratories, Inc.
$30
Mission Pharmacal Company
$28
DENTSPLY IH AB
$27
UROVANT SCIENCES INC
$22
Clarus Therapeutics Inc.
$17
BOSTON SCIENTIFIC CORPORATION
$17
Supernus Pharmaceuticals, Inc.
$14
Top 3 companies account for 73.8% of total payments
Associated products mentioned in payments ›
ALTIS · AQUABEAM SYSTEM · AVEED · Altis · Axium INS DRG IPG · Axonics · Axonics r-SNM System · Axumin · Bulkamid · FEMALE INCONTINENCE · GEMTESA · GENERAL - BPH · JATENZO · KEYTRUDA · LITHOVUE · LOFRIC · LUPRON DEPOT · LoFric · MYRBETRIQ · Myrbetriq · PENILE & TESTICULAR RECONSTRUCTN · PROLARIS · PROLATE · Porges Coloplast · REZUM · SUPERION · SpaceOAR VUE System - 10mL · TITAN · TLANDO · TOVIAZ · Titan · UROLIFT · Uribel · XIAFLEX · XTANDI · XYOSTED · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2 per 100 Medicare services performed
Looking for a urology physician in Conroe?
Compare urology physicians in the Conroe area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
35
Per 100K population
5.3
County median income
$97,266
Nearest hospital
HCA HOUSTON HEALTHCARE CONROE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kwatra is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kwatra experienced with testosterone injection?
Based on Medicare claims data, Dr. Kwatra performed 421,305 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kwatra receive payments from pharmaceutical companies?
Yes. Dr. Kwatra received a total of $9,320 from 28 companies across 162 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kwatra's costs compare to other urology physicians in Conroe?
Dr. Kwatra's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kwatra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →